Reading time: 1 min

Contact dermatitis is an inflammatory skin disease that occurs when the skin comes into contact with external substances capable of causing irritation or triggering an allergic reaction. It can affect people of all ages, though it is more common from middle age onwards, particularly among women and in professions with a higher risk of exposure.

Contact Dermatitis explained in first person

Professionals and patients explain how you live with the disease
Contact dermatitis | PortalCLÍNIC
There are increasingly more treatments available, with fewer adverse effects, and more specific and skin-friendly cosmetics.

Many different substances may be involved, including soaps, cosmetics, fragrances, jewellery and plants. To treat contact dermatitis, it is necessary to identify and avoid the cause of the reaction.  

Types of contact dermatitis

Contact dermatitis is generally classified into two main types:

Person with a genetic predisposition to a skin disorder

Allergic contact dermatitis. Appears when a person is sensitive to a particular substance (allergen) that triggers an immune response in the form of skin lesions that reappear after every instance of exposure to the allergen. 

Showering person with allergy in contact with substance

Irritant contact dermatitis. It occurs when an irritating substance comes into contact with the skin and can affect anyone. 

How many people are affected?

Contact dermatitis affects approximately 15–20% of the general population, and its frequency increasing due to exposure to metals, fragrances and preservatives found in cosmetic, industrial and household products. Although it may appear at any age, its prevalence increases after 40 years of age, affecting twice as many women as men. Women also tend to be affected earlier.  

What is an allergy?

Consulta toda la información relacionada con Allergy

Read more

Substantiated information by:

Published: 25 May 2020
Updated: 25 May 2020

The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.

Subscribe

Receive the latest updates related to this content.

Thank you for subscribing!

If this is the first time you subscribe you will receive a confirmation email, check your inbox

An error occurred and we were unable to send your data, please try again later.